Aarti Pharmalabs Limited — Others, 10-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Aarti Pharmalabs has provided a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations for the quarter ended December 31, 2024. This certificate affirms that securities received for dematerialization were processed and that those securities are listed on the relevant stock exchanges. The report also notes that no demat or remat requests were received or processed during the quarter.

This update indicates operational efficiency in handling securities, which could enhance investor confidence. The neutral impact from the absence of demat requests may mean there is no immediate change in liquidity, but ongoing compliance reflects positively on the company's governance framework.